76979-33-4Relevant articles and documents
Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors
Li, Si-Ning,Xu, Yun-Yun,Gao, Jia-Yu,Yin, Hong-Ran,Zhang, Shi-Lei,Li, Huan-Qiu
, p. 3221 - 3227 (2015/08/03)
Abstract A type of novel rhodanine-based 4-anilinoquinazoline, which designed the combination between quinazoline as the backbone and various substituted biological rhodanine groups as the side chain, have been synthesized, and their antiproliferative act